Janux Therapeutics (JANX) Stock: Buy, Sell, or Hold?
JANX - Janux Therapeutics, Inc. Common Stock
$16.63
-0.43 (-2.55%)
âŧ
5d:
+0.7%
30d:
-0.33%
90d:
+6.78%
WAIT
LOW Confidence
Analysis Updated: Oct 23, 2026 12:00 AM ET
Earnings: Nov 05, 2026
12d
Smart Money Distribution
Options positioning is turning defensive after a sharp run-up - a pattern consistent with institutional profit-taking. View Scanner →
Signal fired Oct 15, 2026 at $17.32 · last confirmed Oct 19, 2026
Strength: 3.6/10
Get Alerted When JANX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: JANX is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: JANX is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: JANX is currently trading at $16.62, which is considered slightly low relative to its 30-day fair value range of $16.47 to $17.61.
Technical Outlook: Technically, JANX is in a uptrend. The price is currently testing key support at $16.43. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: JANX scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. In the options market, Implied Volatility is low (18th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $36.24 (+112.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, JANX is in a uptrend. The price is currently testing key support at $16.43. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: JANX scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. In the options market, Implied Volatility is low (18th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $36.24 (+112.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$16.47 -
$17.61
Company Quality Score
43/100
(HOLD)
Options IV Signal
18th percentile
(COMPLACENCY WARNING)
Volume Confirmation
HIGH
Confidence Score
66.7%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Options cheap (IV 18th percentile)
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 112.4% below Wall St target ($36.24)
- WARNING: Composite score 43/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$16.47 -
$17.61
Current vs Trading Range
SLIGHTLY LOW
Expected Move (7 Days)
Âą$1.59
(9.6%)
Support & Resistance Levels
Support Level
$16.43
Resistance Level
$19.18
Current Trend
Uptrend
Technical data as of
Oct 22, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-6.50
Wall Street Target
$36.24
(+112.4%)
Revenue Growth (YoY)
2177.9%
Share & Embed Analysis
Last updated: October 23, 2026 12:32 PM ET
Data refreshes hourly during market hours. Next update: 1:32 PM
Data refreshes hourly during market hours. Next update: 1:32 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is JANX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
IONS
Ionis Pharmaceuticals Inc |
STRONG BUY
25 analysts |
$84 | 61 BUY |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 50 HOLD |
|
GPCR
Structure Therapeutics IâĻ |
STRONG BUY
16 analysts |
$106 | 50 HOLD |
|
APLS
Apellis Pharmaceuticals âĻ |
BUY
22 analysts |
$41 | 50 HOLD |
|
TSHA
Taysha Gene Therapies Inc |
STRONG BUY
13 analysts |
$13 | 58 HOLD |
